Respiri Ltd
ASX:RSH
Relative Value
The Relative Value of one RSH stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.035 AUD, Respiri Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
RSH Competitors Multiples
Respiri Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
R
|
Respiri Ltd
ASX:RSH
|
55.1m AUD | 29.8 | -7.3 | -7.4 | -7.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.4B USD | 4.4 | 29.9 | 17 | 23.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
172.4B USD | 17.1 | 60.4 | 45.8 | 56.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
140B USD | 5.6 | 43.1 | 21.9 | 26.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
127.3B USD | 3.7 | 26.7 | 15 | 21.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.9B USD | 5.5 | 38.3 | 22.8 | 30.5 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.8B EUR | 2 | 21.6 | 12 | 16.9 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.2B USD | 11.7 | 47.3 | 33.8 | 37.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.5B USD | 2.3 | 30 | 11.4 | 19.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.4B USD | 7.5 | 32.5 | 23 | 25.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36.6B USD | 6.8 | 24.6 | 17.4 | 19.3 |